CARTA CIENTÍFICO-CLÍNICA
Necrólisis epidérmica tóxica por vemurafenib
Toxic epidermal necrolysis induced by vemurafenib
Leído
7372
Vecesse ha leído el artículo
3000
Total PDF
4372
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 63 | 31 | 94 |
| 2025 5 | 76 | 42 | 118 |
| 2025 4 | 85 | 27 | 112 |
| 2025 3 | 95 | 30 | 125 |
| 2025 2 | 87 | 38 | 125 |
| 2025 1 | 62 | 32 | 94 |
| 2024 12 | 84 | 28 | 112 |
| 2024 11 | 73 | 47 | 120 |
| 2024 10 | 59 | 51 | 110 |
| 2024 9 | 52 | 24 | 76 |
| 2024 8 | 69 | 54 | 123 |
| 2024 7 | 68 | 39 | 107 |
| 2024 6 | 86 | 44 | 130 |
| 2024 5 | 57 | 35 | 92 |
| 2024 4 | 74 | 37 | 111 |
| 2024 3 | 70 | 64 | 134 |
| 2024 2 | 47 | 46 | 93 |
| 2024 1 | 55 | 41 | 96 |
| 2023 12 | 44 | 36 | 80 |
| 2023 11 | 48 | 73 | 121 |
| 2023 10 | 47 | 34 | 81 |
| 2023 9 | 48 | 35 | 83 |
| 2023 8 | 46 | 18 | 64 |
| 2023 7 | 65 | 70 | 135 |
| 2023 6 | 49 | 40 | 89 |
| 2023 5 | 74 | 25 | 99 |
| 2023 4 | 67 | 25 | 92 |
| 2023 3 | 66 | 17 | 83 |
| 2023 2 | 71 | 29 | 100 |
| 2022 1 | 33 | 26 | 59 |
| 2022 12 | 62 | 40 | 102 |
| 2022 11 | 74 | 49 | 123 |
| 2022 10 | 91 | 31 | 122 |
| 2022 9 | 79 | 55 | 134 |
| 2022 8 | 71 | 55 | 126 |
| 2022 7 | 64 | 50 | 114 |
| 2022 6 | 40 | 35 | 75 |
| 2022 5 | 65 | 52 | 117 |
| 2022 4 | 47 | 33 | 80 |
| 2022 3 | 61 | 63 | 124 |
| 2022 2 | 46 | 29 | 75 |
| 2021 1 | 99 | 60 | 159 |
| 2021 12 | 53 | 60 | 113 |
| 2021 11 | 59 | 51 | 110 |
| 2021 10 | 54 | 60 | 114 |
| 2021 9 | 62 | 46 | 108 |
| 2021 8 | 55 | 28 | 83 |
| 2021 7 | 59 | 46 | 105 |
| 2021 6 | 62 | 77 | 139 |
| 2021 5 | 57 | 36 | 93 |
| 2021 4 | 103 | 84 | 187 |
| 2021 3 | 70 | 39 | 109 |
| 2021 2 | 77 | 42 | 119 |
| 2020 1 | 63 | 25 | 88 |
| 2020 12 | 40 | 30 | 70 |
| 2020 11 | 32 | 24 | 56 |
| 2020 10 | 31 | 39 | 70 |
| 2020 9 | 51 | 27 | 78 |
| 2020 8 | 35 | 25 | 60 |
| 2020 7 | 28 | 29 | 57 |
| 2020 6 | 45 | 46 | 91 |
| 2020 5 | 35 | 23 | 58 |
| 2020 4 | 36 | 23 | 59 |
| 2020 3 | 42 | 28 | 70 |
| 2020 2 | 3 | 8 | 11 |
| 2020 1 | 7 | 15 | 22 |
| 2019 12 | 4 | 21 | 25 |
| 2019 11 | 6 | 6 | 12 |
| 2019 10 | 0 | 5 | 5 |
| 2019 9 | 0 | 8 | 8 |
| 2019 8 | 4 | 1 | 5 |
| 2019 7 | 4 | 14 | 18 |
| 2019 6 | 4 | 18 | 22 |
| 2019 5 | 4 | 63 | 67 |
| 2019 4 | 2 | 26 | 28 |
| 2019 3 | 3 | 6 | 9 |
| 2019 2 | 0 | 5 | 5 |
| 2019 1 | 5 | 5 | 10 |
| 2018 12 | 0 | 3 | 3 |
| 2018 11 | 5 | 3 | 8 |
| 2018 10 | 2 | 5 | 7 |
| 2018 9 | 191 | 8 | 199 |
| 2018 8 | 0 | 4 | 4 |
| 2018 7 | 0 | 1 | 1 |
| 2018 5 | 1 | 7 | 8 |
| 2018 4 | 2 | 0 | 2 |
| 2018 3 | 1 | 2 | 3 |
| 2018 2 | 21 | 5 | 26 |
| 2018 1 | 30 | 8 | 38 |
| 2017 12 | 41 | 12 | 53 |
| 2017 11 | 17 | 13 | 30 |
| 2017 10 | 22 | 8 | 30 |
| 2017 9 | 3 | 7 | 10 |
| 2017 8 | 4 | 6 | 10 |
| 2017 7 | 3 | 1 | 4 |
| 2017 6 | 12 | 12 | 24 |
| 2017 5 | 7 | 12 | 19 |
| 2017 4 | 10 | 2 | 12 |
| 2017 3 | 7 | 14 | 21 |
| 2017 2 | 6 | 8 | 14 |
| 2016 1 | 12 | 3 | 15 |
| 2016 12 | 12 | 7 | 19 |
| 2016 11 | 7 | 5 | 12 |
| 2016 10 | 5 | 4 | 9 |
| 2016 9 | 0 | 9 | 9 |
| 2016 8 | 2 | 4 | 6 |
| 2016 7 | 7 | 1 | 8 |
| 2016 6 | 10 | 9 | 19 |
| 2016 5 | 10 | 3 | 13 |
| 2016 4 | 8 | 2 | 10 |
| 2016 3 | 0 | 1 | 1 |
| 2015 1 | 0 | 3 | 3 |
| 2015 12 | 0 | 2 | 2 |
| 2015 11 | 0 | 4 | 4 |
| 2015 10 | 0 | 23 | 23 |
Mostrar todo
